Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.06.2023 | Case report

Fingolimod/teriflunomide

Various toxicities following in-utero-exposure: 4 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Platzbecker K, et al. Fingolimod, teriflunomide and cladribine for the treatment of multiple sclerosis in women of childbearing age: description of drug utilization and exposed pregnancies in Germany. Multiple Sclerosis and Related Disorders 67: Nov 2022. Available from: URL: http://doi.org/10.1016/j.msard.2022.104184 Platzbecker K, et al. Fingolimod, teriflunomide and cladribine for the treatment of multiple sclerosis in women of childbearing age: description of drug utilization and exposed pregnancies in Germany. Multiple Sclerosis and Related Disorders 67: Nov 2022. Available from: URL: http://​doi.​org/​10.​1016/​j.​msard.​2022.​104184
Metadaten
Titel
Fingolimod/teriflunomide
Various toxicities following in-utero-exposure: 4 case reports
Publikationsdatum
01.06.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-41859-y

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Zolpidem

Case report

Topiramate

Case report

Carboplatin